Dr. R. Scott Wright is a distinguished cardiologist and researcher at the Mayo Clinic in Rochester, Minnesota. He is a fellow of the American College of Cardiology, the European Society of Cardiology, and the American Heart Association. Dr. Wright's extensive research focuses on acute coronary syndromes, dyslipidemia, type 2 diabetes, and valvular heart disease. He is renowned for his leadership in clinical trials and database studies investigating innovative treatments and healthcare policies. Dr. Wright has been instrumental in groundbreaking advancements in cholesterol treatment, including the development of a novel injectable medication that reduces cholesterol by up to 80%. In this science-focused episode of Radio Maine, Dr. Wright shares insights into this therapy and its potential to transform the treatment of heart disease, the leading cause of death in the United States. He also discusses the promising future of RNA-based therapies and their role in combating a variety of diseases.